Allgens Medical Technology CO., LTD. (SHA:688613)
23.20
+0.91 (4.08%)
Mar 10, 2026, 3:00 PM CST
SHA:688613 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | - | -12.66 | 54.23 | 95.22 | 120.78 | Upgrade
|
| Depreciation & Amortization | - | 18.35 | 18.04 | 18.03 | 13.17 | Upgrade
|
| Other Amortization | - | 6.46 | 4.87 | 2.28 | 1.58 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.64 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | -0.2 | -0.08 | 0.32 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -17.92 | -18.02 | -10.23 | -14.92 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 9.23 | 1.42 | 0.61 | 0.48 | Upgrade
|
| Other Operating Activities | - | -1.4 | 1.86 | -1.71 | 1.8 | Upgrade
|
| Change in Accounts Receivable | - | -21.15 | -30.39 | -12.16 | -9.52 | Upgrade
|
| Change in Inventory | - | -22.35 | -12.71 | 0.71 | 1.83 | Upgrade
|
| Change in Accounts Payable | - | 25.79 | 38.52 | 11.81 | 16.22 | Upgrade
|
| Operating Cash Flow | - | -19.6 | 51.68 | 102.05 | 129.76 | Upgrade
|
| Operating Cash Flow Growth | - | - | -49.36% | -21.35% | 52.89% | Upgrade
|
| Capital Expenditures | - | -13.43 | -21.9 | -45.42 | -61.22 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0 | 0.21 | 0 | - | Upgrade
|
| Cash Acquisitions | - | -24.62 | - | - | - | Upgrade
|
| Investment in Securities | - | -3.63 | -96.57 | -152 | -168.8 | Upgrade
|
| Other Investing Activities | - | 55.89 | 0.19 | 0.03 | 0.53 | Upgrade
|
| Investing Cash Flow | - | 14.22 | -118.08 | -197.39 | -229.49 | Upgrade
|
| Long-Term Debt Issued | - | - | 25 | - | 47.6 | Upgrade
|
| Long-Term Debt Repaid | - | -10.69 | -40.15 | -15.67 | -56.75 | Upgrade
|
| Net Debt Issued (Repaid) | - | -10.69 | -15.15 | -15.67 | -9.15 | Upgrade
|
| Issuance of Common Stock | - | 22.52 | - | - | 508.33 | Upgrade
|
| Common Dividends Paid | - | -10.78 | -17.06 | -40.12 | -1.24 | Upgrade
|
| Other Financing Activities | - | - | - | - | -7.73 | Upgrade
|
| Financing Cash Flow | - | 1.05 | -32.22 | -55.79 | 490.21 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -0.2 | 0 | -0.3 | 0 | Upgrade
|
| Net Cash Flow | - | -4.54 | -98.62 | -151.43 | 390.49 | Upgrade
|
| Free Cash Flow | - | -33.03 | 29.78 | 56.63 | 68.54 | Upgrade
|
| Free Cash Flow Growth | - | - | -47.42% | -17.38% | 140.72% | Upgrade
|
| Free Cash Flow Margin | - | -16.03% | 13.15% | 23.09% | 29.04% | Upgrade
|
| Free Cash Flow Per Share | - | -0.23 | 0.23 | 0.42 | 0.57 | Upgrade
|
| Cash Income Tax Paid | - | 22.93 | 16.52 | 10.57 | 20.5 | Upgrade
|
| Levered Free Cash Flow | - | -22.86 | 18.41 | 5.93 | 11.95 | Upgrade
|
| Unlevered Free Cash Flow | - | -21.02 | 20.36 | 7.09 | 14.09 | Upgrade
|
| Change in Working Capital | - | -20.84 | -10.65 | -2.47 | 6.86 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.